We directed our research towards the study of the A2AR in gliomas, it is an inhibitory checkpoint of the immune system, which by blocking it with an antagonist has shown efficacy in other types of cancer, by improving the anti-tumor immune response [14,15,16,17,18]. The gene discussed is ADORA2A; the disease is glioma.